Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2001;77:441-442; doi:10.1136/pmj.77.909.441
© 2001 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgrad Med J 2001;77:441-442 ( July )

Review

Therapeutic value of octreotide for patients with severe dumping syndrome---a review of randomised controlled trials

J Li-Ling, M Irving

Department of Surgery, Medical School, University of Newcastle upon Tyne, UK

Correspondence to: Professor Sir Miles Irving, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, UK m.h.irving@ncl.ac.uk

Submitted 19 April 2000; Accepted 7 November 2000

The first 150 words of the full text of this article appear below.

    Introduction

Approximately 10%-50% of patients develop some manifestations of the dumping syndrome after gastric surgery. Among them, 5%-10% have clinically significant symptoms, and 1%-2% are debilitated by them.1 Early dumping, typically starting 10-30 minutes after a meal, usually involves both vasomotor and gastrointestinal complaints such as sweating, palpitation, weakness and faintness, abdominal bloating, cramping, and profound diarrhoea. Late dumping, often occurring 2-3 hours postprandially, involves mainly vascular complaints characterised by perspiration, palpitation, mental confusion, and sometimes syncope. It is estimated that, among all affected patients, 75% have early dumping symptoms. The symptoms of early dumping probably result from rapid emptying of hyperosmolar chyme into the small bowel leading to a large fluid shift from the intravascular space into the intestinal lumen, with consequent rapid small bowel distension and an increase in both the amplitude and frequency of bowel contractions. Late dumping is a consequence of reactive hypoglycaemia resulting from an exaggerated . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Musch, M. W., Arvans, D. L., Paris, H., Chang, E. B. (2009). {alpha}2-Adrenergic Receptors Attenuate Secretagogue-Induced Endocytosis and Promote Exocytosis of Intestinal NHE2 and NHE3. J. Pharmacol. Exp. Ther. 330: 818-825 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.